Written question asked by Llew Smith (Labour), in the House of Commons. It was due for an answer on Thursday, 20 March 1997. It was answered by Gerald Malone (Conservative) on Thursday, 20 March 1997 on behalf of the Department of Health.

Dept of Health

Question: Pursuant to his Answer to the honourable Member for Southwark and Bermondsey of 12th March, Official Report, c263W, if the Pluserix MMR vaccine was recommended for approval by the Committee on Safety of Medicines. - The recommendations of the committee are confidential.

Answer: Mr. Smith: To ask the Secretary of State for Health, pursuant to his answer to the hon. Member for Southwark and Bermondsey (Mr. Hughes) of 12 March, Official Report, column 263, if the Pluserix MMR vaccine was recommended for approval by the Committee on Safety of Medicines; and if he will make a statement. [21302] Mr. Malone: Marketing authorisations are granted by the Licensing Authority. When appropriate, the advice of the Committee on Safety of Medicines is sought. However, the recommendations of the committee are confidential.

Secondary information